tetano
Editor, Senior Moderator
Int J Risk Saf Med. 2011 Jan 1;23(2):113-5.
Vaccine safety.
Labadie J.
Source
WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden.
Abstract
Brief reports are presented on Swissmedic's experiences with PaniFlow?, a tool to monitor Adverse Events Following Immunization (AEFI) of pandemic influenza (H1N1) 2009 vaccines and UMC's updates on AEFI of these vaccines; on WHO's Global Network for Post-marketing Surveillance of Prequalified Vaccines and India joining the network; the June 2010 meeting of the Global Advisory Committee on Vaccine Safety.
PMID:
21673419
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21673419
Vaccine safety.
Labadie J.
Source
WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden.
Abstract
Brief reports are presented on Swissmedic's experiences with PaniFlow?, a tool to monitor Adverse Events Following Immunization (AEFI) of pandemic influenza (H1N1) 2009 vaccines and UMC's updates on AEFI of these vaccines; on WHO's Global Network for Post-marketing Surveillance of Prequalified Vaccines and India joining the network; the June 2010 meeting of the Global Advisory Committee on Vaccine Safety.
PMID:
21673419
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21673419